Menu
Search
|

Menu

Close
X

Integra LifeSciences Holdings Corp IART.OQ (NASDAQ Stock Exchange Global Select Market)

52.20 USD
+0.57 (+1.10%)
As of 3:01 PM GMT
chart
Previous Close 51.63
Open 51.62
Volume 9,594
3m Avg Volume 189,249
Today’s High 52.47
Today’s Low 51.62
52 Week High 56.39
52 Week Low 40.51
Shares Outstanding (mil) 78.08
Market Capitalization (mil) 4,021.81
Forward P/E 62.69
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.33 Mean rating from 15 analysts

KEY STATS

Revenue (mm, USD)
FY17
541
FY16
992
FY15
883
EPS (USD)
FY17
0.222
FY16
0.934
FY15
0.096
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
62.69
32.90
Price to Sales (TTM)
vs sector
3.84
5.77
Price to Book (MRQ)
vs sector
4.46
5.41
Price to Cash Flow (TTM)
vs sector
28.06
23.42
Total Debt to Equity (MRQ)
vs sector
98.37
16.52
LT Debt to Equity (MRQ)
vs sector
96.98
12.22
Return on Investment (TTM)
vs sector
3.66
14.43
Return on Equity (TTM)
vs sector
7.77
16.13

EXECUTIVE LEADERSHIP

Stuart Essig
Independent Chairman of the Board, Since 2012
Salary: --
Bonus: --
Richard Caruso
Non-Executive Independent Chairman of the Board Emeritus, Since 2017
Salary: --
Bonus: --
Peter Arduini
President, Chief Executive Officer, Director, Since 2012
Salary: $878,763.00
Bonus: $1,400,000.00
Glenn Coleman
Chief Financial Officer, Corporate Vice President, Since 2017
Salary: $481,600.00
Bonus: $400,000.00
Lisa Evoli
Corporate Vice President, Chief Human Resources Officer, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

311 Enterprise Dr
PLAINSBORO   NJ   08536-3344

Phone: +1609.2750500

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

SPONSORED STORIES